Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000227393, also known as AL031575.1, is a human pseudogene with sequence similarity to a region of the p38 interacting protein (P38IP), which itself is associated with transcriptional regulation[1][3]. As a pseudogene, AL031575.1 is not expected to produce a functional protein product. Pseudogenes can sometimes have regulatory effects at the RNA level, such as acting as competing endogenous RNAs ("miRNA decoys"), influencing the expression of other genes, or being processed into small interfering RNAs, but there is no evidence in public annotation databases or the literature supporting such a role for this specific pseudogene[5]. This entity is not considered a canonical drug target or valid disease biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of transcription factor (p38 interacting protein) (AL031575.1).